Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 B2 Impact B2IO Apr 24, 2025 10.60 +1.15   
 B3 Consulting Group B3 Apr 24, 2025 59.00 +1.37   
 Backaheden Fastighets BACKA Apr 24, 2025 64.00 -1.54   
 Bactiguard Holding B BACTIB Apr 24, 2025 29.10 -3.64   
 Bahnhof B BAHNB Apr 24, 2025 54.00 +2.47   
 Balco Group BALCO Apr 24, 2025 27.90 -6.38   
 Balder B BALDB Apr 24, 2025 67.88 -0.06   
 Bambuser BUSER Apr 24, 2025 0.51 +3.13   
 Bawat Water Technologies BAWAT Apr 24, 2025 0.96 +6.08   
 BE Group BEGR Apr 24, 2025 40.80 -4.11   
 Beammwave B BEAMMWB Apr 24, 2025 5.92 +1.37   
 Beijer Alma B BEIAB Apr 24, 2025 181.20 +1.23   
 Beijer Ref B BEIJB Apr 24, 2025 149.70 +6.17   
 Beowulf Mining SDB BEOSDB Apr 24, 2025 1.55 -3.13   
 Bergman & Beving B BERGB Apr 24, 2025 292.00 +1.39   
 Berner Industrier AB BERNERB Apr 24, 2025 49.40 +1.86   
 Besqab BESQAB Apr 24, 2025 22.60 -1.31   
 Besqab Pref B BESQABPREFB Apr 24, 2025 85.00 +0.24   
 Betsson B BETSB Apr 24, 2025 156.60 -0.70   
 Better Collective BETCO Apr 24, 2025 119.70 +0.17   
 Beyond Frames BEYOND Apr 24, 2025 9.96 -0.20   
 BHG Group BHG Apr 24, 2025 25.88 +1.41   
 BiBBInstruments BIBB Apr 24, 2025 2.95 -1.34   
 BICO Group BICO Apr 24, 2025 38.72 +3.92   
 Bilia A BILIA Apr 24, 2025 120.40 +0.42   
 Billerud AB BILL Apr 24, 2025 99.45 -0.25   
 BIMobject BIM Apr 24, 2025 7.80 -0.89   
 Binero Group BINERO Apr 24, 2025 2.20 0.00   
 Bio Vitos Pharma BIOVIT Apr 24, 2025 0.12 0.00   
 Bio-Works Technologies BIOWKS Apr 24, 2025 1.26 -2.70   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.